跳至主要内容
临床试验/NCT00301626
NCT00301626已完成不适用

ROSCAP: Reduction of Smoking in Cardiac Patients Study

National Institutes of Health (NIH)2 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2000年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
180
试验地点
2
主要终点
Smoking reduction

研究概览

简要总结

Background. The ROSCAP Study was a randomized controlled trial in heart disease patients to test the effect of a smoking reduction intervention on cigarettes per day (cpd) and biochemical and clinical indicators of tobacco exposure. .

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • smoked at least 15 cigarettes per day and had one of 11 cardiovascular disorders: history of myocardial infarction, coronary artery bypass surgery, angioplasty, stent placement, thrombolytic therapy, angina, arrhythmia, a history of cardiac arrest, greater than 50% coronary artery stenosis by angiography, ischemia on exercise tolerance testing or congestive heart failure, required to confirm that they were unwilling or uninterested in setting a stop smoking date in the next 30 days.

排除标准

  • unstable angina within the past 2 weeks, 2) unstable psychiatric or substance use disorders or 3) contraindications to nicotine replacement therapy (including pregnancy or intention to become pregnant)

结局指标

主要结局

Smoking reduction

次要结局

  • Smoking cessation, biomarker measures

研究者

申办方类型
Nih

研究点 (2)

Loading locations...

相似试验